Exelixis (EXEL) Current Assets (2010 - 2026)
Exelixis' (EXEL) quarterly Current Assets came in at $1.2 billion in Q2 2026, down 13.45% year-on-year from $1.4 billion in Q2 2025, and down 16.26% quarter-over-quarter from $1.4 billion in Q1 2026.
Exelixis (EXEL) Current Assets (2010 - 2026) Analysis & Trends
Exelixis' Current Assets history runs 17 years deep, the most recent figure standing at $1.2 billion for Q2 2026.
- On a quarterly basis, Current Assets fell 13.45% year-over-year to $1.2 billion in Q2 2026; TTM through Apr 2026 was $1.2 billion, a 13.45% decrease from a year earlier, with the FY2026 full-year figure at $1.4 billion, down 1.66% from the prior year.
- Current Assets declined to $1.2 billion in Q2 2026 per EXEL's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Current Assets topped out at $1.9 billion in Q3 2022 and bottomed at $1.2 billion in Q3 2025.
- The 5-year median for Current Assets is $1.5 billion (2025), against an average of $1.5 billion.
- Across the five-year window, Current Assets climbed 28.48% in 2022 and decreased 21.63% in 2023, its largest moves.
- Year by year, Current Assets stood at $1.6 billion in 2022, then declined by 18.58% to $1.3 billion in 2023, then rose by 17.58% to $1.5 billion in 2024, then fell by 9.52% to $1.4 billion in 2025, then slipped by 13.81% to $1.2 billion in 2026.
- Per Business Quant, the three latest EXEL Current Assets figures stand at $1.2 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.21 Bn |
| Jan 2, 2026 | 1.44 Bn |
| Oct 3, 2025 | 1.40 Bn |
| Jul 4, 2025 | 1.18 Bn |
| Apr 4, 2025 | 1.40 Bn |
| Jan 3, 2025 | 1.47 Bn |
| Sep 27, 2024 | 1.55 Bn |
| Jun 28, 2024 | 1.48 Bn |
| Mar 29, 2024 | 1.29 Bn |
| Dec 29, 2023 | 1.32 Bn |
| Sep 29, 2023 | 1.44 Bn |
| Jun 30, 2023 | 1.59 Bn |
| Mar 31, 2023 | 1.64 Bn |
| Dec 30, 2022 | 1.62 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jul 1, 2022 | 1.85 Bn |
| Apr 1, 2022 | 1.84 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Oct 1, 2021 | 1.66 Bn |
| Jul 2, 2021 | 1.59 Bn |